DRUG PRODUCT DEVELOPMENT & MANUFACTURING

Your CDMO for molecules that demand more.

Across oral, nasal, pulmonary and sterile drug products, we step up where others turn away.

ABOUT UPPERTON

The same people. The same understanding. At every stage.

Most CDMOs hand your programme on. Between phases, between teams, between sites - knowledge gets lost, decisions get repeated, and momentum stalls.

Upperton is structured differently.

One iste, senior scientists and leadership who stay close to your molecule from first formulation to final product. R&D, GMP and QC operating without handovers, without gaps, and without the risk that comes from fragmented development.

Your molecule never leaves the hands that understand it. That's not how every CDMO works. It's how we work.

Track Record

0 +

Years of formulation expertise across oral, nasal, pulmonary and parenteral dosage forms.

FACILITY

0 sq.ft

development and manufacturing facility in Nottingham, UK

03 — Investment

0 OEB5

Capital invested in our 60,000 sq ft GMP facility at Trent Gateway, Nottingham.

YOUR STRATEGIC CDMO PARTNER

Partner with Upperton

We provide fully integrated services across every stage of drug product development:

01 — Development and Manufacturing

End-to-end CDMO for Small & Mid-size Biotech

Upperton combines advanced formulation expertise, integrated development capabilities, and single-site execution to ensure speed, efficiency, and control at every stage of your drug product journey.

With 25+ years of expertise in dry powder formulations and complex dosage forms, we take full ownership of your molecule’s lifecycle from early-stage development to clinical supply and beyond.

Our model is built around:

When you are ready to begin your CDMO journey, Upperton specialises in:

Inhalation drug products (pulmonary delivery)
Oral solid dosage form tablets and capsules
Oral solid dosage forms (OSD)
Nasal drug delivery systems
Parenteral formulations

Let's work together

How can we help you?